A remedy against obesity? The role of lactoferrin in the metabolism of glucose and lipids
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2012, Vol 66, Issue 0
Abstract
Obesity, dyslipidemia, hyperglycemia/type II diabetes and hypertension together constitute the so-called metabolic syndrome. Frequency of occurrence of these serious metabolic disturbances is associated with life style and is on the rise in prosperous industrialized countries. These diseases represent not only a serious health problem but also social and economic ones, and involve in prophylaxis and treatment various specialists (physicians, dieticians and psychologists). For about two decades research has been conducted on the possibility to apply milk-derived proteins in prevention and treatment of the above mentioned metabolic diseases. Lactoferrin (LF), a protein present in milk and excretory fluids of mammals, is one of the most intensively studied milk proteins for therapeutic application. Initial trials revealing an advantageous effect of LF on lipid metabolism and obesity enrolled only a few volunteers and were performed in Japan in 2003. Subsequent trials were conducted on animals as well as in clinics, and the positive results were supported by in vitro tests. After oral administration of LF, decreases of body weight, waist measurement, visceral fat tissue, plasma and liver fatty acid concentrations, triglycerides and cholesterol were registered. The mechanism of LF action may involve several processes, such as inhibition of adipogenesis, decrease of dietary triglyceride absorption, elevation of HDL cholesterol possessing anti-atherogenic properties, inhibition of accumulation of oxidized LDL cholesterol forms in macrophages and protection against formation of foam cells. LF also increases the susceptibility of cells to insulin action, including in conditions when the response to insulin is lowered (during inflammation). In addition, LF regulates activity of insulin-like growth factor (IGF). The data collected to date indicate that LF is a promising, completely nontoxic, natural remedy which (as for example a food supplement) may be applied in long-term prophylaxis and therapy of metabolic disturbances, such as dyslipidemia, obesity and insulin resistance/type II diabetes.
Authors and Affiliations
Jolanta Artym
Keywords
Related Articles
- EP ID EP66829
- DOI -
- Views 151
- Downloads 0
Cukrzyca typu 2 a choroba Alzheimera – jedna czy dwie choroby? Mechanizmy asocjacji
Zarówno wynik badań epidemiologicznych, jak i wyniki licznych prac z zakresu patofizjologiiwskazują na podobieństwo i na związek dwóch amyloidoz – cukrzycy typu 2 (diabetes mellitustype 2 – DM2, non-insulin dependent dia...
“Vicious circles” of glioblastoma tumors: vascularization and invasiveness
Glioblastoma multiforme is the most common and a particularly aggressive form of glial primary brain tumors. This malignancy accounts for ca. 70% of all diagnosed cases. Unfortunately, average survival of glioma patients...
Oculomotor disturbances in HIV-positive individuals treated with methadone
Methadone substitution is claimed to be the most effective way of pharmacological management of human immunodeficiency virus (HIV) positive patients addicted to opioids. Possible and clinically the most relevant drug int...
Reakcja nadwrażliwości kontaktowej, jej mechanizm i regulacja
Reakcja nadwrażliwości kontaktowej (CS) na hapteny jest klasycznym przykładem odpowiedzi komórkowej. W reakcji tej można wyróżnić dwie kolejno po sobie występujące fazy: wczesną występującą już 2 godziny od kolejnego kon...
Rola zewnątrzkomórkowych pęcherzyków błonowych w interakcji pasożyt-żywiciel
Zewnątrzkomórkowe pęcherzyki błonowe (EVs, extracellular vesicles), początkowo uważane za elementy zniszczonych komórek, okazały się niezwykle istotnym sposobem przekazywania informacji między komórkami, bez ich bezpośre...